Valuation: Center Laboratories, Inc.

Market Cap 29.08B 903M 790M 729M 674M 1.28B 86.22B 1.3B 8.73B 3.42B 42.34B 3.39B 3.32B 147B P/E 2024
-28.2x
P/E 2025 3.64x
Enterprise Value 33.12B 1.03B 900M 830M 768M 1.46B 98.2B 1.48B 9.94B 3.9B 48.22B 3.86B 3.78B 167B EV / Sales 2024
22.3x
EV / Sales 2025 23.1x
Free-Float
73.35%
Yield 2024
1.71%
Yield 2025 4.21%
1 day-1.02%
1 week+1.43%
Current month+2.10%
1 month+3.04%
3 months-1.89%
6 months-4.77%
Current year-6.37%
1 week 38.75
Extreme 38.75
40.55
1 month 36.8
Extreme 36.8
40.55
Current year 36.8
Extreme 36.8
51.4
1 year 33.1
Extreme 33.1
51.4
3 years 29.12
Extreme 29.1236
58.79
5 years 29.12
Extreme 29.1236
58.79
10 years 20.99
Extreme 20.9884
64.21
Manager TitleAgeSince
Chief Executive Officer - 03/08/1998
Director of Finance/CFO - 08/12/2022
Chief Tech/Sci/R&D Officer - 01/07/1983
Director TitleAgeSince
Chairman - 30/11/2022
Director/Board Member 61 14/06/2010
Director/Board Member - 14/06/2010
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%+1.43%+11.66%-20.38% 903M
-1.61%-1.32%+49.78%+161.33% 1,085B
+0.13%-0.33%+63.92%+62.05% 624B
-0.39%-2.10%+27.90%+85.44% 442B
+0.52%-1.03%+28.17%+27.09% 332B
-3.14%-10.27%+22.08%+27.43% 277B
+0.44%-2.63%+25.55%+45.21% 282B
+0.31%-2.03%-29.70%-39.68% 217B
-0.02%-1.26%+20.45%+61.00% 196B
-1.59%+2.84%+16.37%+76.09% 167B
Average -0.58%-1.86%+23.62%+48.56% 362.28B
Weighted average by Cap. -0.74%-1.06%+35.66%+81.96%

Financials

2024 2025
Net sales 1.62B 50.26M 43.97M 40.54M 37.51M 71.2M 4.8B 72.39M 486M 190M 2.36B 189M 185M 8.16B 1.52B 47.1M 41.2M 38M 35.16M 66.73M 4.5B 67.84M 455M 178M 2.21B 177M 173M 7.65B
Net income -1.1B -34.29M -29.99M -27.66M -25.59M -48.57M -3.27B -49.38M -331M -130M -1.61B -129M -126M -5.57B 9.32B 290M 253M 234M 216M 410M 27.64B 417M 2.8B 1.1B 13.57B 1.09B 1.06B 47.02B
Net Debt 4.48B 139M 122M 112M 104M 197M 13.28B 200M 1.34B 527M 6.52B 522M 511M 22.6B 4.04B 126M 110M 101M 93.71M 178M 11.98B 181M 1.21B 475M 5.88B 471M 461M 20.38B
Logo Center Laboratories, Inc.
Center Laboratories Inc is a Taiwan-based company engaged in the development of pharmaceutical products. The Company's products mainly focus on internal liquids, including syrups, suspensions, liquids and other dosage forms. Pharmacological classifications include respiratory tract therapeutics such as cough suppressants, sputum expectorants, asthma medications, and runny nose relief, while antipyretic and analgesic medications and gastrointestinal medications are also in great demand, and a variety of internal liquids and lozenges for the treatment of central nervous system (CNS) such as epilepsy, dysphoria, dementia, and Parkinson's disease have already been introduced into the market. The Company is a specialized manufacturer of internal liquid.
Employees
-
Date Price Change Volume
09/07/26 NT$38.95 -1.02% 1,354,313
08/07/26 NT$39.35 -0.38% 2,447,035
07/07/26 NT$39.50 -0.75% 2,544,596
06/07/26 NT$39.80 +0.38% 4,071,591
03/07/26 NT$39.65 +3.26% 8,219,167
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. 4123 Stock